114 related articles for article (PubMed ID: 26469166)
1. [An Elderly Patient with Non-Small Cell Lung Cancer Who Responded to Salvage S-1 Monotherapy after Gefitinib Therapy].
Mouri A; Hamamoto Y; Kameyama N; Ibe T; Takeoka S; Honma C; Fukusumi M; Kamimura M
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1091-3. PubMed ID: 26469166
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of recurrent non-small cell lung cancer successfully treated with S-1 as fifth-line chemotherapy].
Takakuwa O; Oguri T; Sato S; Nakao M; Ohta C; Iwashima Y; Miyazaki M; Maeno K; Kutsuna T; Nakamura A; Ueda R
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1721-4. PubMed ID: 19838034
[TBL] [Abstract][Full Text] [Related]
3. [Three cases of long-term control of non-small-cell lung cancer via S-1 monotherapy in elderly patients].
Numata T; Osawa H; Homma Y; Yanai H; Endo T
Gan To Kagaku Ryoho; 2015 Mar; 42(3):379-82. PubMed ID: 25812513
[TBL] [Abstract][Full Text] [Related]
4. [A case of non-small cell lung cancer responding to S-1 over a year].
Tsurumaki H; Tomizawa Y; Tsuchiya T; Suzuki J; Iijima H; Yoshii A; Watanabe S; Sato K; Kamide Y; Mori M; Saito R
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2147-9. PubMed ID: 21084815
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of effective S-1 monotherapy for patients with metastatic adenocarcinoma of the lung after multiple previous chemotherapies].
Hata A; Nanjo S; Otsuka K; Kida Y; Higashi Y; Kaji R; Fujita S; Katakami N
Gan To Kagaku Ryoho; 2009 May; 36(5):807-10. PubMed ID: 19461182
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404.
Nishiyama O; Taniguchi H; Kondoh Y; Takada K; Baba K; Saito H; Sugino Y; Yamamoto M; Ogasawara T; Kondo M; Imaizumi K; Hasegawa Y; Suzuki R; Shimokata K;
Anticancer Drugs; 2011 Sep; 22(8):811-6. PubMed ID: 21317767
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of gefitinib monotherapy in chemotherapy-naïve patients of 75 years or older with advanced non-small cell lung cancer.
Ebi N; Semba H; Tokunaga SJ; Takayama K; Wataya H; Kuraki T; Yamamoto H; Akamine SJ; Okamoto I; Nakanishi Y;
J Thorac Oncol; 2008 Oct; 3(10):1166-71. PubMed ID: 18827614
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancer.
Govindan R; Morgensztern D; Kommor MD; Herbst RS; Schaefer P; Gandhi J; Saito K; Zergebel C; Schiller J
J Thorac Oncol; 2011 Apr; 6(4):790-5. PubMed ID: 21325974
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of erlotinib for acquired resistance to gefitinib in patients with advanced non-small cell lung cancer.
Horiike A; Yamamoto N; Tanaka H; Yanagitani N; Kudo K; Ohyanagi F; Ono A; Naito T; Murakami H; Horai T; Nishio M
Anticancer Res; 2014 Apr; 34(4):1975-81. PubMed ID: 24692734
[TBL] [Abstract][Full Text] [Related]
10. [S-1 monotherapy in patients with pretreated advanced non-small cell lung cancer].
Hashizume T; Nakada Y
Gan To Kagaku Ryoho; 2009 Jun; 36(6):963-7. PubMed ID: 19542716
[TBL] [Abstract][Full Text] [Related]
11. [A case of complete response treated by S-1 with concurrent radiotherapy for a gefitinib-resistant non-small cell lung cancer patient].
Fujimoto H; Oyama T; Suito T; Hashimoto K; Kameyama Y; Yasuda H; Ishizuka H
Gan To Kagaku Ryoho; 2010 Feb; 37(2):295-8. PubMed ID: 20154488
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine).
Kobayashi S; Fujino N; Suzuki S; Yanai M
Respirology; 2009 Jul; 14(5):771-2. PubMed ID: 19659655
[TBL] [Abstract][Full Text] [Related]
13. Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Hockenhull J; Proudlove C; Dundar Y; Richardson M; Dickson R; Mullard A; Marshall E
Health Technol Assess; 2015 Jun; 19(47):1-134. PubMed ID: 26134145
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.
Imai H; Minemura H; Kishikawa T; Yamada Y; Suzuki K; Umeda Y; Wasamoto S; Kasahara N; Ishihara S; Yamaguchi O; Naruse I; Uchino J; Mori K; Kanazawa K; Shibata Y; Kasai T; Kaburagi T; Kaira K; Minato K
Thorac Cancer; 2020 Oct; 11(10):2867-2876. PubMed ID: 32844570
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of salvage chemotherapy in the advanced non-small cell lung cancer patients who failed the treatment of chemotherapy and EGFR-TKI].
Fan Y; Huang ZY; Yu HF; Luo LH
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):859-63. PubMed ID: 21223694
[TBL] [Abstract][Full Text] [Related]
16. [A case of multidrug-resistant non-small cell lung cancer responding to TS-1].
Imai H; Sunaga N; Kaira K; Ishihara S; Aoki H; Iijima H; Yanagitani N; Iwasaki Y; Tomizawa Y; Saito R; Mori M
Gan To Kagaku Ryoho; 2007 Feb; 34(2):221-4. PubMed ID: 17301531
[TBL] [Abstract][Full Text] [Related]
17. [Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1].
Hirose T; Hosaka T; Nakashima M; Sugiyama T; Ishida H; Yamaoka T; Okuda K; Adachi M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):327-30. PubMed ID: 18281776
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated
with More Than Two Lines of Chemotherapy].
Yin Y; Wu B; Huang Z; Zhuang W; Xu Z; Huang C; Huang Y; Zhang J
Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):437-444. PubMed ID: 29945701
[TBL] [Abstract][Full Text] [Related]
19. [A case of non-small cell lung cancer with EGFR mutation responding to S-1 after a therapy with gefitinib].
Kawano O; Yano M; Sasaki H; Yukiue H; Okuda K; Fujii Y
Gan To Kagaku Ryoho; 2009 Apr; 36(4):675-7. PubMed ID: 19381047
[TBL] [Abstract][Full Text] [Related]
20. [A case of pulmonary pleomorphic carcinoma treated with S-1 following radiotherapy].
Komatsu Y; Hama M; Shinagawa Y; Yoshikawa S; Gomi K; Yamashita K; Nakamura T; Honda T; Hachiya T
Gan To Kagaku Ryoho; 2012 Apr; 39(4):687-9. PubMed ID: 22504704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
